Skip to main content
Premium Trial:

Request an Annual Quote

Kathleen Wiltsey, Neil Cook

Premium
Sequenom has elected Kathleen Wiltsey to its board of directors. Wiltsey joined Amgen in 1984 as business development manager and served in a variety of roles at the company, including vice president, before retiring in 1998. She is also executive director for the development and launch of the Archon X Prize for Genomics, a board member of Lexicon Pharmaceuticals, and president elect of the board of the associates of the California Institute of Technology.
 

 
Agilent Technologies has appointed Neil Cook as vice president and director of the Molecular Technology Laboratory at Agilent Laboratories. Cook also will serve as the research and development/technology manager for Agilent's Life Sciences and Chemical Analysis business. In this role, he will be responsible for guiding the future technology direction and R&D strategy for LSCA across its life sciences, materials science, and chemical analysis businesses.
 
Prior to joining Agilent, Cook was vice president for research and business development and chief scientific officer of PerkinElmer’s Life and Analytical Sciences division. Previously, Cook held vice president positions at Amersham Biosciences (now part of GE Healthcare) in corporate development, drug discovery marketing, and R&D.

The Scan

Plan Rebuffed

The Associated Press reports China has rejected the World Health Organization's proposal to include the lab-leak theory in the next phase of its investigation into the origins of SARS-CoV-2.

Opossum Change

Researchers from Riken have used CRISPR to edit marsupial genomes, as Technology Review reports.

In the Ice

Cosmos magazine reports that researchers have uncovered more than two dozen ancient viruses in a Tibetan glacier.

Nature Papers Present Method to Uncover Differential RNA Modifications, Neutrophils in Innate Immune Response

In Nature this week: computational approach to identifying differential RNA modifications, and more.